Clinical trials
Phase 1 Neoplasm Metastasis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 11 |
| 2022 | 11 |
| 2023 | 13 |
| 2024 | 12 |
| 2025 | 11 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 31 |
| Unknown status | 18 |
| Completed | 14 |
| Active, not recruiting | 10 |
| Not yet recruiting | 5 |
| Terminated | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 6 |
| Eli Lilly and Company | 6 |
| Chinese PLA General Hospital | 3 |
| Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| BeOne Medicines | 2 |
| BeiGene | 2 |
| Beijing Mabworks Biotech Co., Ltd. | 2 |
| Betta Pharmaceuticals Co., Ltd. | 2 |
| Boehringer Ingelheim | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 83 |
| Ovarian Neoplasms | 11 |
| Breast Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Uterine Cervical Neoplasms | 9 |
| Neoplasms | 8 |
| Stomach Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Carcinoma, Renal Cell | 6 |
| Esophageal Neoplasms | 6 |
Trials
Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.